NORGINE B.V. COMPLETES ACQUISITION OF MERUS LABS INTERNATIONAL INC. STRENGTHENING ITS LEADING POSITION IN THE EUROPEAN SPECIALIST PHARMA MARKET17 July 2017
MERUS LABS INTERNATIONAL INC. RECEIVES COURT APPROVAL IN CONNECTION WITH PROPOSED PLAN OF ARRANGEMENT WITH NORGINE B.V.13 July 2017
Sign up for Norgine alerts
We are looking for suitable partners to commercialise our products in territories where we do not have a direct presence – Asia Pacific, Americas, and ROW.
Treatment of chronic, severe spasticity of skeletal muscle in adults
Treatment of malignant hyperthermia